Your browser doesn't support javascript.
loading
Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein Charge.
Kannan, Aadithya; Chinn, Michael; Izadi, Saeed; Maier, Andrew; Dvornicky, James; Fedesco, Mark; Day, Eric; Ladiwala, Asif; Woys, Ann.
Afiliação
  • Kannan A; Department of Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.
  • Chinn M; Department of Purification Development, 1 DNA Way, South San Francisco, CA 94080, United States.
  • Izadi S; Department of Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.
  • Maier A; Department of Purification Development, 1 DNA Way, South San Francisco, CA 94080, United States.
  • Dvornicky J; Department of Purification Development, 1 DNA Way, South San Francisco, CA 94080, United States.
  • Fedesco M; Department of Purification Development, 1 DNA Way, South San Francisco, CA 94080, United States.
  • Day E; Department of Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.
  • Ladiwala A; Department of Purification Development, 1 DNA Way, South San Francisco, CA 94080, United States.
  • Woys A; Department of Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States. Electronic address: woysa@gene.com.
J Pharm Sci ; 112(3): 820-829, 2023 03.
Article em En | MEDLINE | ID: mdl-36336103
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ultrafiltração / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pharm Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ultrafiltração / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pharm Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos